Split Creek Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Split Creek Capital's LLY Position: Q3 2026 in Review
Split Creek Capital reduced its Eli Lilly (LLY) stake by 37% in Q3 2026, selling an estimated $192K and leaving 280 shares worth $324K. The position accounts for 0.31% of the portfolio, ranked #100.
Split Creek Capital first reported a position in LLY in Q1 2026 and has held it in 3 quarters since. The position peaked at $531K in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Split Creek Capital held 280 shares of Eli Lilly worth $324K as of Q3 2026.
- Split Creek Capital sold 163 Eli Lilly shares in Q3 2026, an estimated $192K.
- Eli Lilly made up 0.31% of Split Creek Capital's portfolio in Q3 2026, its #100 holding.
- Split Creek Capital first reported a position in Eli Lilly in Q1 2026 and has held it in 3 quarters since.
- Split Creek Capital's Eli Lilly position peaked at $531K in Q2 2026.
- 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Split Creek Capital's 13F filing for Q3 2026, filed 2 Nov 2026.